Wall Street's AI-Semiconductor Bet Faces Worst Momentum Investing Performance

Since July, momentum investing—which involves buying rising stocks and shorting underperformers—has seen a sharp decline, with Wall Street investors who bet on artificial intelligence (AI) and semiconductor strength suffering significant losses.
According to the Wall Street Journal, while the S&P 500 index rose 2.8% since July, the S&P 500 momentum index fell more than 9%. Bank of America reported that the momentum strategy posted its largest loss since April 2009 during the global financial crisis. If this trend continues through August, the momentum index could record its worst quarterly performance in 25 years relative to the broader market.
Momentum investors this year bought AI beneficiaries like NVIDIA, AMD, and Micron while shorting stocks expected to be hurt by AI expansion. This strategy propelled the S&P 500 momentum index to a 44% rise in Q2 alone—the highest quarterly gain on record. Over the past five years, it has risen 133%, nearly double the market's overall return.
However, as more capital flows into similar strategies, the risk of a sudden reversal increases, with a recent shift triggered by a sharp rise in biotech stocks. Moderna jumped approximately 150% in August alone after positive news about a cancer vaccine developed with Merck, prompting quant and hedge funds that had bet against the stock to quickly buy back shares, amplifying the upward trend.
More investors are now betting on declines in previously strong stocks. According to the U.S. Commodity Futures Trading Commission, speculative traders' net short positions in Nasdaq-100 futures have reached a 20-year high. While market indices rise, analysts note that winners and losers are rapidly switching places across individual stocks.
Korean Source
This article is an English localization of a Korean-language crypto news report. Original headline: AI·반도체株만 믿었던 월가…모멘텀 투자 '최악 성적' 위기